2023
Vironova BioAnalytics is Acquired by Quatre Lab
29/11/2023Vironova BioAnalytics AB Acquired by an investor syndicate, led by Quatre Lab, to expand its TEM services for the pharmaceutical industry;... Read More
Minoryx announces enrollment of first patients with cerebral Adrenoleukodystrophy
17/11/2023Minoryx announces enrollment of first patients with cerebral Adrenoleukodystrophy (cALD) in US Phase 3 clinical trial, CALYX As part of CALYX,... Read More
The Director of Quatre Lab Receives an Award for Her Brilliant Career
13/11/2023Patricia Muñoz, Doctor in Biomedical Research and Director of the affiliated company Quatre Lab, receives an award for her career in... Read More
Artax Granted Clinical Trial Authorization for AX-158 Phase 2a Psoriasis Study
10/11/2023Artax Granted Clinical Trial Authorization for AX-158 Phase 2a Psoriasis Study Patient Enrollment Expected to Begin by Year End. Phase 2a... Read More
AURA Receives FDA Agreement(SPA) for Belzupacap in Early-stage Choroidal Melanoma
06/11/2023Aura Biosciences Receives FDA Agreement Under Special Protocol Assessment (SPA) for CoMpass Phase 3 Clinical Trial of Belzupacap Sarotalocan (Bel-sar) in... Read More
ARTHEx Biotech in the 3rd Annual Needham Private Biotech Company Virtual Forum
11/10/2023ARTHEx Biotech to Participate in the 3rd Annual Needham Private Biotech Company Virtual 1x1 Forum Valencia, Spain, October 11, 2023 –... Read More
Quatre Lab establishes itself in the Gipuzkoa Science and Technology Park.
04/10/2023The pioneering company in advanced therapy quality control, establishes itself in the Gipuzkoa Science and Technology Park. QUATRE LAB, a new... Read More
CVP BioSpain sponsor´s 2023, one of the Europe´s largest events
26/09/2023From September 26th to 28th, Barcelona, a hub of healthcare innovation in Europe, will host BIOSPAIN The vibrant city of Barcelona... Read More
Artax Biopharma Announces Positive Phase 1 Results for AX-158
07/06/2023Aleta Biotherapeutics Granted MHRA Clinical Trial Authorization for Biologic CAR T-Cell Engager ALETA-001. Aleta’s lead program, ALETA-001 has clinical support from... Read More
Minoryx gains FDA approval to patients with cALD
31/05/2023Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral Adrenoleukodystrophy US trial with leriglitazone to... Read More